Abstract
Osteoporosis is a major health issue in all Western countries, affecting approximately 25% to 30% of all postmenopausal women. It is not a disease with a single cause but rather a heterogeneous disease process involving a number of contributing etiologic factors.1 It is well established that skeletal mass diminishes with aging but the relative contributions of genetic and environmental factors are still unknown.2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Riggs BL. Pathogenesis of osteoporosis. Am J Obstet Gyncol. 1987;156:1342–1346.
Heaney RP, Gallagher JC, Johnston CC, et al. Calcium nutrition and bone health in elderly. Am J Clin Nutr. 1982;36:986–1013.
Raisz LG. Osteoporosis. J Am Geriatr Soc 1982;30:127–138.
Dawson-Hughes B. Osteoporosis and aging: gastrointestinal aspects. J Am Coll Nutr. 1986; 5:393–398.
Heaney RP, Recker RR. Effects of nitrogen, phosphorus, and caffeine on calcium balance in women. J Lab Clin Med. 1982;99:46–55.
Heaney RP, Recker RR, Stegman MR, Moy AJ. Calcium absorption in women: relationships to calcium intake, estrogen status and age. J Bone Min Res. 1989;4:469–475.
Nordin BEC, ed. Calcium, Phosphate and Magnesium Metabolism. New York, NY: Churchill Livingstone; 1976.
Matkovic V, Kostial K, Simonivoc I, et al. Bone status and fracture rates in two regions in Yugoslavia. Am J Clin Nutr. 1979;32:540–549.
Garn SM. The earlier gain and the later loss of cortical bone in nutritional perspective. Springfield, IL: Charles C Thomas; 1970.
Smith RW, Frame B. Concurrent axial and appendicular osteoporosis: its relation to calcium consumption. N Engl J Med. 1986;273: 72–78.
Caroll MD, Abrahams S, Dresser CM. Dietary intake source data, United States, 1976–80 (PHS 83–1681). National Center for Health Statistics. Washington, DC: Government Printing Office; March 1983.
Scythes CA, Gibson RS, Draper HH. Dietary calcium and phosphorus intakes of a sample of Canadian premenopausal women consuming self-selected diets. Nutr Res. 1982;2:385–396.
Delvin EE, Imbach A, Copti M. Vitamin D nutritional status and related biochemical indices in an autonomous elderly population. Am J Clin Nutr. 1988;48:373–378.
Morgan DB. Osteomalacia, renal osteodystrophy and osteoporosis. Springfield, IL: CC Thomas; 1973.
Cummings JH, Hill MJ, Jivraj T, Houston H, Branch WJ, Jenkins DJA. The effect of meat protein and dietary fiber on colonic function and metabolism, I. Changes bowel habit, bile acid excretion and calcium absorption. Am J Clin Nutr. 1979;32:2086–2093.
Kelsay J., Behall KM, Prather ES. Effect of fiber from fruits and vegetables on metabolic responses of human subjects. II. Calcium, magnesium, iron and silicon balances. Am J Clin Nutri. 1979;32:1876–1880.
Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, De Luca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.J Clin Invest. 1979;64:729–736.
Newcomer AD, Hodgson SF, McGill DB, Thomas PJ. Lactase deficiency: prevalance in osteoporosis. Ann Intern Med. 1978;89:218–220
Donath A, Nordio S, Macagno F, Gatti R. The effect of hydrochlorothiazide on calcium and strontium transport in intestine and kidney. Heiv Paediat Acta. 1971;25:293–300.
Gursel E. Effects of diuretics on renal and intestinal handling of calcium. N.Y. State J Med. 1970;70:399–405.
Harrison AR, Ross GA. The effect of bendrofluozide on urinary and faecal calcium and phosphorus. Clin Sci. 1986;34:343–350.
LaCroix AZ, Wienpahl J, White LR, et al. Thiazide diuretics and the incidence of hip fractures. N Engl J Med. 1990;322:286–290.
Dent CE, Richens A, Rowe DKF, Stamp TCB. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Brit Med J. 1970;4:69–72.
Saville D. Changes in bone mass with age and alcoholism. J Bone Joint Surg. 1965;47A:492–499.
Nilsson BE, Bestlin NE. Changes in bone mass in alcoholics. Clin Orthop. 1973;90:229–232.
Spencer H, Lender M. Adverse effects of aluminum-containing antacid or mineral metabolism. Gastroenterology. 1979;76:603–606.
Spencer H, Kramer L, Osis D, Norris C. Effect of phosphorus on the absorption of calcium and on the calcium balance in man. J Nutr. 1978;108:7–57.
McParland BE, Goulding A, Campbell AJ. Dietary salt affects biochemical markers of resorption and formation of bone in elderly women. Brit Med J. 1989;299:834–835.
Need AG, Morris HA, Cleghorn DB, DeNichilo D, Horowitz M, Nordin BEC. Effect of salt in postmenopausal women. Arch Int Med. 1991;151:757–764.
Johnson NE, Alcantara EN, Linkswiler HM. Effect of protein intake on urinary and fecal calcium and calcium retention of young adult males. J Nutr. 1970;100:1425–1428.
Nordin BEC. The pathogenesis of osteoporo sis. Lancet. 1961;1:1011–1014.
Stepan JJ, Pospichal J, Presl J, Packovsky V. Bone loss and biochemical indices of bone remodelling in surgically induced postmeno pausal women. Bone. 1987;8:279–284.
Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med. 1978;92:964–970.
Gallagher JC, Goldgar D, Moy A. Total bone calcium in normal women: effect of age and menopause status. J Bone Min Res. 1987;2: 491–496.
Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab. 1990;71:1288–1293.
Heaney RP, Recker RR, Saville PD. Meno pausal changes in calcium balance perfor mance. J Lab Clin Med. 1978;92:953–963.
Riffs B, Thomsen K, Christiansen C. Does calcium supplementation prevent postmenopausal bone loss? N Engl J Med. 1987;316:173–177
National Institutes of Health Osteoporosis Consensus Development Conference Statement. JAMA. 1984;252:799–802.
Bullamore JR, Wilkinson R, Gallagher JC, Nordin BEC, Marshall DH. Effect of age on calcium absorption. Lancet. 1970;2:535–537.
Ireland P, Fordtran JS. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest. 1973;52:2672–2681.
Ackerman PG, Toro G. Calcium balance in elderly women. J Gerontol. 1954;9:446–449.
Sutnick MR. Nutrition: calcium, cholesterol and calories. Med Clin North Am. 1987;71:123–134.
Fisher CJ. Nutrition’s role in determining the quality of life. Geriatric Medicine. 1986;2:183–186.
Allen LH. Calcium bioavailability and absorption: a review. Am J Clin Nutr. 1982;35:783–808.
Kaye M. Dietary calcium and calcium supplerestriction on urine hydroxyproline excretion mentation. Mod Med Canada. 1986;41:3–12.
Gorecki D, Richardson J, et al. Dissolution rates in calcium carbonate tablets, a consid eration in product selection. Can Pharm J. 1989;144:485–508.
Recker RR. Calcium absorption and achlorhydria. N Eng J Med. 1985;313:70–73.
Carr CJ, Shangraw RF. Nutritional and pharmaceutical aspects of calcium supplementation. Am Pharm. 1987;27:49.
Pak CV, Khashayar S, et al. Nephrolithiasis from calcium supplementation. J Urol. 1987; 137:1212–1213.
Keyler D, Peterson CD. Oral calcium supplements: how much of what, for whom, and why? Postgrad Med. 1985;78:123–125.
Khashayar S, Nicar MJ, Glass K, Zerwekn JE, Pak CYC. Reduction in intestinal calcium absorption by hydrochlorthiazide in postmeno pausal osteoporosis. J Clin Endocrinol Metab. 1984;59:1037–1043.
Calcium supplements (Systemic). In: United States Pharmacopeial Convention USP DI, VOl1A, Drug Information for the Health Care Professional. Rockville: United States Pharmacopeial Convention; 1991:766–775.
Storm T, Thamsborg G, et al. Effect of inter mittent cyclical etidronate therapy on bone mass and fracture rate in women with post menopausal osteoporosis. N Eng J Med. 1990; 332;1265–1271.
Arnold R, Wermeille M, et al. Influence of food and antiacid administration of fluoride bioavailability from enteric-coated sodium fluoride tablets. Bone. 1989;10:401–407.
Drug interactions facts. ed. D.S. Tatro. St. Louis: J.B. Lippincott Company; 1993:43.
Calcium salts. In: Physician’s 1989 Drug Handbook. Pennsylvania: Springhouse; 1989: 155–157.
Reid IR., Schooler BA, Hannan SF, Ibbertson HK. The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med. 1986;16:193–197.
Food and Drug Administration. Advice on limiting intake of bone meal. FDA Drug Bull. 1982;12:5–6.
Stamp TCB, Haddad JG, Twigg CA. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet. 1977;1:1341–1343.
Stamp TCB, Round JM. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature. 1974;247:563–565.
Roginsky MS, Moo HF, Abesamis C. Season variations in serum 25-hydroxycholecalciferol. Lancet. 1974;1:1235–1236.
Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly: season substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr. 1987;45:755–763.
Aaron JE, Gallagher JC, Anderson J, et al. Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet. 1974;1:229–233.
Sowers MR, Wallace RB, Hollis BBW, Lemke JH. Parameters related to 25-OH-D levels in a population-based study of women. Am J Clin Nutr. 1986;43:621–628.
Delvin EE, Imbach A, Copti M. Vitamin D nutritional status and related biochemical indices in an autonomous elderly population. Am J Clin Nutr. 1988;48:373–378.
Gibson RS, Draper HH, McGirr LG, et al. The vitamin D status of a cohort of postmenopausal non-institutionalized Canadian women. Nutri Research. 1986;6:1179–1187.
Reid IR, Gallagher DJA, Bosworth J. Prophylaxis against vitamin D deficiency in the elderly by regular sunlight exposure. Age Ageing. 1986;15:35–40.
Lips P, Van Ginkel FC, Jongen MJM, et al. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr. 1987;46:1005–10.
Egsmose C, Lund B, McNair P, et al. Low serum levels of 25-hydroxyvitamin D and1,25 dihydroxyvitamin D in institutionalized old people: influence of solar exposure and vitamin D supplementation. Age & Ageing. 1987;16:35–40.
Jones G, Byrnes B, Duthie D, Jeejeebhoy KN. Contribution of skin vitamin D3 synthesis in patients receiving total parenteral nutrition. In: Norman AW, Schaefer K, Herrath DV, et al., eds. Vitamin D: Basic Research and Its Clinical Application. Berlin: Walter de Gruyter; 1979:169–172.
Anderson J, Campbell AER, Dunn A, Runciman JBM. Osteomalacia in elderly women. Scot Med J. 1966;82:429–435.
Chalmers J, Conacher WDH, Gardner DL, Scott PJ. Osteomalacia-a common disease in elderly women. J Bone Joint Surg. 1976; 49B:403–423.
Webster SGP, Leeming JT, Wilkinson EM. The causes of osteomalacia in the elderly. Age Aging. 1976;5:119–122.
Meredith SC, Rosenberg IH. Gastrointestinal- hepatic disorders and osteomalacia. Clin Endocrinol Metab. 1980;9:131–150.
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992; 327:1637–1642.
Lips P, Wiersinga A, Van Ginkel FC, et al. The effect of vitamin D supplementation on vita min D status and parathyroid function in elderly subjects. J Clin Endocrin & Metab. 1988;67:644–649.
Dawson-Hughes B, Dallal GE, Krall EA, Sa sowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. New Eng J Med. 1990;323:878–883.
Burnell JM, Baylink DJ, Chestnut CH, Teubner EJ. The role of skeletal calcium deficiency in postmenopausal osteoporosis. Calcif Tissue Int. 1986;38:187–192.
Corless D, Dawson E, Fraser F, Ellis M. Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing. 1985;14:76–84.
Krolner B, Nielsen SP, Lund B, Lund BJ, Sorensen OH, Jacobsen S. Lumar spine bone mineral content in post-menopausal osteoporosis. (Abstract) Calcif Tissue Int. 1980;31S: 77A.
Shiraki M, Orimo H, Ito H, et al. Long-term treatment of postmenopausal osteoporosis with active vitamin D3 1-alphahydroxychole calciferol and 1,24-dihydroxycholecalciferol. Endocrinol Jpn. 1985;32:305–315.
Aloia JF, Vaswani A, Yeh J, Ellis K, Yasumura S, Cohn S. Calcitriol in the treatmentof postmenopausal osteoporosis. Am J Med.1988;84:401–408.
Shiraki M, Orimo H, Ito H, Akiguchi I, Nakao J, Takahashi R. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1-OHD3) and 1,24-dihydroxycholecalciferol(1,24(OH)2D3). Endocrinol Jpn. 1985;32:305–315.
Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med. 1990; 113:649–655.
Ott SM, Chestnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989;110:267–274.
Tilyard M. 1,25 dihydroxyvitamin D3 versus calcium in the treatment of established postmenopausal osteoporosis. J Bone Min Res. 5(S2) 1990.
Johnston CC, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med. 1992:327:82–87.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Gallagher, J.C., Fillion, A. (1994). Calcium and Vitamin D . In: Lorrain, J., Plouffe, L., Ravnikar, V.A., Speroff, L., Watts, N.B. (eds) Comprehensive Management of Menopause. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4330-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4330-4_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8737-7
Online ISBN: 978-1-4612-4330-4
eBook Packages: Springer Book Archive